C. Diener

发表

Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.

P. Malherbe, C. Kratzeisen, Pari Malherbe, 2003, Molecular pharmacology.

Constitutive activity modulation of human metabotropic glutamate 5a receptors in HEK293 cells: a role for key amino‐terminal cysteine residues

J. Piussi, C. Diener, Christophe Fischer, 2005, British journal of pharmacology.

Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors

M. Gassmann, B. Bettler, A. Augustin, 2020, Neuropharmacology.

cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein.

P. Malherbe, C. Diener, J. Richards, 1999, Brain research. Molecular brain research.

Comprehensive in vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu®) and oseltamivir active metabolite

H. Loetscher, M. Brockhaus, H. Jacobsen, 2008 .

CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor

W. Spooren, T. Hartung, Aubin Michalon, 2011, Journal of Pharmacology and Experimental Therapeutics.

Determination of key amino acids implicated in the actions of allosteric modulation by 3,3'-difluorobenzaldazine on rat mGlu5 receptors.

Andreas Mühlemann, P. Malherbe, N. Ward, 2006, European journal of pharmacology.

Antisecretory effect of prostaglandin D2 in rat colon in vitro: action sites.

C. Diener, M. Diener, W. Rummel, 1991, American Journal of Physiology.

Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

T Kendall Harden, Richard C Boucher, T. K. Harden, 2003, Molecular pharmacology.

Microsoft Word-Revised CTEP-Text Body_05-08-2011_final

W. Spooren, T. Hartung, Aubin Michalon, 2011 .